Insmed (INSM) Current Deferred Revenue (2010 - 2014)
Insmed (INSM) posted Current Deferred Revenue of $423000.0 for Q4 2014, up 31.78% on a QoQ basis from $321000.0 in Q3 2014, and up 227.91% year-over-year from $129000.0 in Q4 2013.
Powered by 
Analysis
Insmed (INSM) Current Deferred Revenue (2010 - 2014) Analysis & Trends
Insmed has reported Current Deferred Revenue for 5 years, with the latest figure at $423000.0 in Q4 2014.
- On a quarterly basis, Current Deferred Revenue rose 227.91% year-over-year to $423000.0 in Q4 2014; TTM through Dec 2014 was $423000.0, a 227.91% increase from a year earlier, with the FY2014 full-year figure at $423000.0, up 227.91% from the prior year.
- Current Deferred Revenue was $423000.0 for Q4 2014 at Insmed, up from $321000.0 in the prior quarter.
- The five-year high for Current Deferred Revenue was $423000.0 in Q4 2014, with the low at $121000.0 in Q1 2014.
- Average Current Deferred Revenue over 5 years is $209875.0, with a median of $153000.0 recorded in 2012.
- The sharpest annual moves came in 2012 and 2014: Current Deferred Revenue slumped 64.13% in 2012, then soared 227.91% in 2014.
- Over 5 years, Current Deferred Revenue stood at $402000.0 in 2010, then plunged by 61.19% to $156000.0 in 2011, then slipped by 4.49% to $149000.0 in 2012, then dropped by 13.42% to $129000.0 in 2013, then jumped by 227.91% to $423000.0 in 2014.
- The last three Current Deferred Revenue figures came in at $423000.0 (Q4 2014), $321000.0 (Q3 2014), and $167000.0 (Q2 2014), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 236.37 Bn | 222.38 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 187.38 Bn | 184.12 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 138.36 Bn | 130.51 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 85.09 Bn | 77.10 Bn | 3.93 Bn |
| 5 | Argenx Se | 63.93 Bn | 58.75 Bn | 1.37 Bn |
| 6 | Moderna | 58.07 Bn | 52.94 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 35.59 Bn | 32.28 Bn | 992.69 Mn |
| 8 | Biogen | 32.63 Bn | 31.34 Bn | 1.96 Bn |
| 9 | Insmed | 27.57 Bn | 26.41 Bn | 358.27 Mn |
| 10 | BioNTech SE | 26.24 Bn | 12.58 Bn | 10.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2014 | 423,000.00 |
| Sep 30, 2014 | 321,000.00 |
| Jun 30, 2014 | 167,000.00 |
| Mar 31, 2014 | 121,000.00 |
| Dec 31, 2013 | 129,000.00 |
| Sep 30, 2013 | 134,000.00 |
| Jun 30, 2013 | 139,000.00 |
| Mar 31, 2013 | 144,000.00 |
| Dec 31, 2012 | 149,000.00 |
| Sep 30, 2012 | 151,000.00 |
| Jun 30, 2012 | 152,000.00 |
| Mar 31, 2012 | 154,000.00 |
| Dec 31, 2011 | 156,000.00 |
| Sep 30, 2011 | 421,000.00 |
| Jun 30, 2011 | 195,000.00 |
| Dec 31, 2010 | 402,000.00 |